15.3 C
New York
Friday, September 29, 2023

Investing In ZyVersa Therapeutics Inc. (NASDAQ: ZVSA): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for ZyVersa Therapeutics Inc. (ZVSA) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.0066, or 5.14%, to $0.1351. The ZyVersa Therapeutics Inc. has recorded 3,435,119 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed ZyVersa Therapeutics Announces Research Published in Frontiers in Immunology Reinforcing IC 100’s Rationale for Inhibiting Multiple Inflammasomes to Control Inflammation in Various Inflammatory Diseases.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $0.13 and fluctuated between $0.1288 as its day high and $0.1104 as its day low. The current market capitalization of ZyVersa Therapeutics Inc. is $3.88M. A total of 7.81 million shares were traded on the day, compared to an average of 2.36M shares.

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, ZVSA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 9 BUYs and 0 SELLs from insiders. Insiders purchased 3,565,310 shares during that period but sold 0.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for ZVSA in the last 3 months, the mean price target is $2.50 with high estimates of $2.50 and low estimates of $2.50. In terms of 52-week highs and lows, ZVSA has a high of $25.00 and a low of $0.11.

As of this writing, ZVSA has an earnings estimate of -$0.16 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.16 per share and a lower estimate of -$0.16.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ZVSA’s latest balance sheet shows that the firm has $328.58k in Cash & Short Term Investments as of fiscal 2021. There were $9.15M in debt and $13.63M in liabilities at the time. Its Book Value Per Share was $1.12, while its Total Shareholder’s Equity was -$12.50M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZVSA is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles